Epitomyze Inc. Acquires Profect Medical, LLC

Pioneers in clinical photography combine assets, expertise and talent to deliver new vision

Pound Ridge, NY (January 25, 2016, )- Epitomyze Inc., a developer of advanced mobile imaging software and services, announced today that it has acquired Profect Medical Technologies, LLC, a leading provider of clinical photography equipment, software and services. Freddy Jones, founder and President of Profect, will assume the role of CEO at Epitomyze, effective immediately. John B. Duer, Managing Director of TrestleBrook, LLC, a lead investor and Director in Epitomyze, will be assuming the role of COO.

“Profect has developed a deep understanding of the market needs and opportunities in clinical photography, and now has well over a thousand customers on four continents,” said Jones. "We are thrilled to become part of Epitomyze, which brings not only capital, but significant intellectual property, a seasoned and talented team, and strategic vision to the relationship.”

“We see Profect’s experience with image acquisition systems and it’s industry leading image storage and management software as strategic assets that are scaleable and highly complementary to Epitomyze's product pipeline," said Duer. “And we believe that Freddy’s experience and leadership building Profect, and his vision for the future of the combined businesses can generate significant value for Epitomyze’s shareholders."

About Epitomyze™ Inc.
Epitomyze™ Inc. is a team of healthcare and medical imaging experts devoted to revolutionizing the role of clinical photography in medicine. Our three solutions, the epitomyze™ capture app, Profect® clinical photography systems, and ImageStore® cloud-based image management and storage, cover the full spectrum of clinical photography needs. Paired with our helpful resources and industry-leading staff, our solutions increase patient satisfaction, provider satisfaction and productivity, and drive down costs while helping to grow reputation and practice.

Questions concerning this release should be directed to John B. Duer at (203) 969-5230.